Yu Jing, Liu Feng, Cui Shu-Jian, Liu Yan, Song Zheng-Yu, Cao Hui, Chen Feng-E, Wang Wei-Jun, Sun Tao, Wang Fang
The First People Hospital affiliated to Shanghai Jiaotong University, Shanghai, P. R. China.
Proteomics. 2008 Sep;8(17):3667-78. doi: 10.1002/pmic.200700824.
Proliferative vitreoretinopathy (PVR) is the most common cause of anatomic failure in retinal detachment surgery. To understand the molecular mechanisms, vitreous proteomes of patients with PVR were investigated by two-dimensional-nano-liquid chromatography coupled with tandem mass spectrometry. Vitreous samples of moderate PVR (grade B), and severe PVR (grade C or D) were aspirated during pars plana vitrectomy before infusion. In the current study, 129, 97 and 137 proteins were identified in vitreous of normal control, moderate and severe PVR, respectively. In PVR vitreous samples, complement components, serine proteinase inhibitors, and extracellular proteins were up-regulated or appeared, while normal cytoskeleton and metabolism proteins were down-regulated or disappeared. It was noteworthy that the proteins involved in transcription and translation regulation increased in vitreous with PVR. Among 102 PVR-specific proteins, kininogen 1 was specifically detected in both vitreous and the corresponding serum. Therefore, it can be concluded that PVR is a complicated pathology process with great amount of proteins involved in metabolism dysfunction, immune reactions, and cytoskeleton remolding. Kininogen 1 may be a candidate biomarker of PVR. Further investigations of these special proteins will provide additional targets for treatment or prevention of ocular proliferative diseases.
增殖性玻璃体视网膜病变(PVR)是视网膜脱离手术中解剖学失败的最常见原因。为了解其分子机制,通过二维纳米液相色谱与串联质谱联用技术对PVR患者的玻璃体蛋白质组进行了研究。在灌注前的玻璃体切割术中抽取中度PVR(B级)和重度PVR(C级或D级)患者的玻璃体样本。在本研究中,正常对照、中度和重度PVR患者的玻璃体中分别鉴定出129、97和137种蛋白质。在PVR玻璃体样本中,补体成分、丝氨酸蛋白酶抑制剂和细胞外蛋白上调或出现,而正常的细胞骨架和代谢蛋白下调或消失。值得注意的是,参与转录和翻译调控的蛋白质在PVR玻璃体中增加。在102种PVR特异性蛋白质中,激肽原1在玻璃体及其相应血清中均被特异性检测到。因此,可以得出结论,PVR是一个复杂的病理过程,有大量蛋白质参与代谢功能障碍、免疫反应和细胞骨架重塑。激肽原1可能是PVR的候选生物标志物。对这些特殊蛋白质的进一步研究将为眼部增殖性疾病的治疗或预防提供额外的靶点。